To corroborate whether GHR antagonism can sensitize melanoma to chemotherapy, as indicated by our earlier in vitro studies, we intradermally inoculated GHA and WT mice with Fluc-B16-F10 cells on the flank. The gene discussed is GHR; the disease is melanoma.